Rise of biologics set to continue, says report
According to a new report, biologics are forecast to have $120 billion greater sales than small molecules by 2027.
List view / Grid view
According to a new report, biologics are forecast to have $120 billion greater sales than small molecules by 2027.
A Phase III trial evaluating Libtayo® (cemiplimab) monotherapy in advanced cervical cancer has been stopped early due to a positive result on overall survival.
The EMA will assess the marketing authorisation for the medication to see whether it is a cause of skin cancer in patients.
Clinical trial results provide evidence that using the generic skin cream fluorouacil 5 percent for two to four weeks may reduce the risk of SCC...
Researchers have combined low-intensity electric current with a formulation containing nano-encapsulated chemotherapy to treat skin cancer...